Intuitive Surgical, Inc. Increase (Decrease) in Other Accrued Liabilities
Intuitive Surgical, Inc. (ISRG) reported Increase (Decrease) in Other Accrued Liabilities of $219.30 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2018-02-02
- Intuitive Surgical, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2012-12-31 was -$2.20M, a 116.18% decline year-over-year.
- Intuitive Surgical, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2012-09-30 was -$12.10M.
- Intuitive Surgical, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2012-06-30 was $6.70M, a 51.80% decline year-over-year.
- Intuitive Surgical, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2012-03-31 was -$4.70M.
- Intuitive Surgical, Inc. increase (decrease) in other accrued liabilities for fiscal 2017 was $219.30M, a 307.62% increase from fiscal 2016.
- Intuitive Surgical, Inc. increase (decrease) in other accrued liabilities for fiscal 2016 was $53.80M.
- Intuitive Surgical, Inc. increase (decrease) in other accrued liabilities for fiscal 2015 was -$10.50M, a 116.56% decline from fiscal 2014.
- Intuitive Surgical, Inc. increase (decrease) in other accrued liabilities for fiscal 2014 was $63.40M, a 471.17% increase from fiscal 2013.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accrued Liabilities 12 month | Increase (Decrease) in Other Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $219.30M 10-K · filed 2018-02-02 | |||||||
| 2016-12-31 | $53.80M 10-K · filed 2018-02-02 | |||||||
| 2015-12-31 | -$10.50M 10-K · filed 2018-02-02 | |||||||
| 2014-12-31 | $63.40M 10-K · filed 2017-02-06 | |||||||
| 2013-12-31 | $11.10M 10-K · filed 2016-02-02 | |||||||
| 2012-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | -$14.30M derived: sum of 2 quarters · filed 2015-02-06 | -$7.60M derived: sum of 3 quarters · filed 2015-02-06 | -$12.30M 10-K · filed 2015-02-06 | ||||
| 2012-09-30 | -$12.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-18 | -$5.40M derived: sum of 2 quarters · filed 2012-10-18 | -$10.10M 10-Q · filed 2012-10-18 | $3.50M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2012-06-30 | $6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-23 | $2.00M 10-Q · filed 2012-07-23 | $15.60M derived: sum of 3 quarters · filed 2014-02-03 | $3.40M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2012-03-31 | -$4.70M 10-Q · filed 2012-04-19 | $8.90M derived: sum of 2 quarters · filed 2014-02-03 | -$3.30M derived: sum of 3 quarters · filed 2014-02-03 | $10.60M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2011-12-31 | $13.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03 | $1.40M derived: sum of 2 quarters · filed 2014-02-03 | $15.30M derived: sum of 3 quarters · filed 2014-02-03 | $7.90M 10-K · filed 2014-02-03 | ||||
| 2011-09-30 | -$12.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-18 | $1.70M derived: sum of 2 quarters · filed 2012-10-18 | -$5.70M 10-Q · filed 2012-10-18 | -$8.90M 10-Q · filed 2011-10-19 | -$17.20M derived: sum of 4 quarters · filed 2013-02-04 | |||
| 2011-06-30 | $13.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-23 | $6.50M 10-Q · filed 2012-07-23 | -$5.00M derived: sum of 3 quarters · filed 2013-02-04 | $8.40M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2011-03-31 | -$7.40M 10-Q · filed 2012-04-19 | -$18.90M derived: sum of 2 quarters · filed 2013-02-04 | -$5.50M derived: sum of 3 quarters · filed 2013-02-04 | $22.30M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2010-12-31 | -$11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-04 | $1.90M derived: sum of 2 quarters · filed 2013-02-04 | $29.70M derived: sum of 3 quarters · filed 2013-02-04 | $38.20M 10-K · filed 2013-02-04 | ||||
| 2010-09-30 | $13.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-19 | $41.20M derived: sum of 2 quarters · filed 2011-10-19 | $49.70M 10-Q · filed 2011-10-19 | $50.00M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2010-06-30 | $27.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-20 | $36.30M 10-Q · filed 2011-07-20 | $36.60M derived: sum of 3 quarters · filed 2012-02-06 | $45.80M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2010-03-31 | $8.50M 10-Q · filed 2011-04-20 | -$14.10M 10-Q · filed 2010-04-20 | $8.80M derived: sum of 2 quarters · filed 2012-02-06 | $18.00M derived: sum of 3 quarters · filed 2012-02-06 | $40.60M derived: sum of 4 quarters · filed 2012-02-06 | |||
| 2009-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $9.50M derived: sum of 2 quarters · filed 2012-02-06 | $32.10M derived: sum of 3 quarters · filed 2012-02-06 | $32.60M 10-K · filed 2012-02-06 | $32.61M 10-K · filed 2010-01-29 | |||
| 2009-09-30 | $9.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-20 | $31.80M derived: sum of 2 quarters · filed 2010-10-20 | $32.30M 10-Q · filed 2010-10-20 | $32.31M 10-Q · filed 2009-10-21 | $49.10M derived: sum of 4 quarters · filed 2011-02-01 | |||
| 2009-06-30 | $22.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-23 | $23.10M 10-Q · filed 2010-07-23 | $23.09M 10-Q · filed 2009-07-23 | $39.90M derived: sum of 3 quarters · filed 2011-02-01 | $50.23M derived: sum of 4 quarters · filed 2011-02-01 | |||
| 2009-03-31 | $500.00K 10-Q · filed 2010-04-20 | $17.30M derived: sum of 2 quarters · filed 2011-02-01 | $27.63M derived: sum of 3 quarters · filed 2011-02-01 | |||||
| 2008-12-31 | $16.80M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-01 | $27.13M derived: sum of 2 quarters · filed 2011-02-01 | $34.70M 10-K · filed 2011-02-01 | $34.69M 10-K · filed 2010-01-29 | ||||
| 2008-09-30 | $10.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | $17.90M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | $7.57M 10-Q · filed 2009-07-23 | |||||||
| 2007-12-31 | $7.89M 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |